A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo
- 1 January 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 96 (1) , 71-73
- https://doi.org/10.1111/j.1365-2133.1977.tb05188.x
Abstract
Clobetasol proprionate (CP) (0.05%) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Of 23 patients, 12 partially repigmented during 4 mo. treatment with CP. All patients showed dermal atrophy with the CP.This publication has 8 references indexed in Scilit:
- Treatment of vitiligo with O.1% betamethasone 17-valerate in isopropyl alcohol—a double-blind trialBritish Journal of Dermatology, 1974
- The clinical evaluation of a new topical corticosteroid, clobetasol propionate.British Journal of Dermatology, 1974
- Treatment of Vitiligo by Local Application of Betamethasone 17-Valerate in a Dimethyl Sulfoxide Cream BaseDermatology, 1973
- On the etiology of vitiligo and gray hairPublished by Elsevier ,1971
- Treatment of Localized Vitiligo with Intradermal Injections of Triamcinolone AcetonideDermatology, 1970
- Vitiligo – Response to 0.2 % Betamethasone 17-Valerate in Flexible CollodionDermatology, 1970
- AUTOANTIBODIES IN PATIENTS WITH VITILIGOThe Lancet, 1969
- Method for Comparing Percutaneous Absorption of SteroidsArchives of Dermatology, 1962